Shareholders meeting

Concord Biotech Limited held its 41st Annual General Meeting on July 31, 2026, through video conferencing. The meeting was attended by 38 members, and the requisite quorum was present. The Chairman and Managing Director, Mr. Sudhir Vaid, addressed the shareholders and gave an overview of the company's operations and financial performance for the year ended March 31, 2026. The meeting concluded with the approval of the Notice convening the 41st Annual General Meeting and the Directors' Report, which had already been circulated to the members.